Pseudohyperkalemia in a Patient With Chronic Lymphocytic Leukemia

Rahul Gujarathi1, Venu Chippa2, Narsimha Candula1

  • 1Hospital Medicine, University of Florida Health, Jacksonville, USA.

Cureus
|April 4, 2022
PubMed

Insights

Pseudohyperkalemia, a false high potassium reading, can occur in chronic lymphocytic leukemia (CLL) patients due to fragile white blood cells. Clinicians should confirm true hyperkalemia before treatment to avoid unnecessary interventions.

Area of Science:

  • Hematology
  • Clinical Chemistry
  • Internal Medicine

Background:

  • Hyperkalemia is a critical electrolyte imbalance with serious cardiac implications.
  • Distinguishing true hyperkalemia from pseudohyperkalemia is essential for appropriate patient management.

Observation:

  • A 63-year-old male with chronic lymphocytic leukemia (CLL) presented with markedly elevated serum potassium levels (up to 8.4 mmol/L).
  • Despite high serum potassium, venous blood gas analysis revealed normal plasma potassium (3.7-4.4 mmol/L), indicating pseudohyperkalemia.

Findings:

  • Mechanical stress, such as blood sample centrifugation, can lyse fragile white blood cells in CLL patients.
  • This lysis releases intracellular potassium, leading to falsely elevated serum potassium concentrations (pseudohyperkalemia).

Implications:

  • Clinicians must be aware of pseudohyperkalemia in CLL patients with high white blood cell counts.
  • Recognizing spurious laboratory values prevents unnecessary treatments and invasive diagnostic procedures.
  • This case highlights the importance of specific diagnostic methods like venous blood gas analysis to confirm true electrolyte disturbances.

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.2K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
131
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
70
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
831
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
94